Trial

A Placebo-Controlled, Phase 2 Trial to Evaluate OPC 67683 in Patients With Pulmonary Sputum Culture-Positive, Multidrug-Resistant Tuberculosis (TB)

Study Director
Start Date
4 / 2008
Trial Phase
Trial Status
published
Current Enrollment
Target Enrollment
Overview
Developer Associations
Otsuka Pharmaceutical Development & Commercialization, Inc.
Compound Associations
Delamanid